Skip to content

Evaluation of Sunscreens Under Actual Use Conditions

A Single Center, Randomized, Split-Face, Double-Blinded, Single Sun Exposure Evaluation of Sunscreens of SPF 50+ and Above Under Actual Use Conditions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02952235
Enrollment
199
Registered
2016-11-02
Start date
2016-03-31
Completion date
2016-03-31
Last updated
2017-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sun Protection

Brief summary

Use of two high SPF sunscreens under actual use conditions.

Detailed description

To evaluate the difference in the level of sunburn (erythema) protection following a single period of natural sunlight exposure afforded by application of SPF 50+ and SPF 100+ sunscreens.

Interventions

OTHERSPF50+

Sun protection

OTHERSPF100+

Sun protection

Sponsors

Johnson & Johnson Consumer and Personal Products Worldwide
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Males and Females with Fitzpatrick Skin Types I-III 2. At least 18 years old 3. Able to read, write, speak and understand the English language. 4. Has personally read, signed, and dated the Informed Consent Form (including HIPAA disclosure) and Photograph Release 5. Generally in good health based on medical history reported by the subject 6. Healthy male or female subjects with no history or evidence of clinically relevant medical disorder, as determined from a brief medical history interview. 7. Willing and able to follow the study instructions, including: Remain outdoors for at least 5 hours on Day 1 during the study with face and neck uncovered (as much as possible) * Apply the test products (sunscreen) to designated sides of the face and neck * Remove any make-up, sunscreen, or other facial products at baseline prior to applying test product. Use test product in place of current sun protection topical skincare products (this includes make-up) * Attend scheduled visits and intend to successfully complete the study * Return ALL study products at Day 2 exit visit * Refrain from using other sunscreen products or tanning bed use during the duration of the study.

Exclusion criteria

1. Individuals with known allergies or sensitivities to sunscreens or any ingredient contained in the test products or common topical skincare products, including adhesives. 2. Observable Sunburn (erythema score above 0.5) on the face and neck as determined by the PI or designee. 3. Women known to be pregnant or nursing. 4. Individuals with any disease or condition of the skin (e.g., active \[i.e. flaring\] eczema or psoriasis, skin cancer, polymorphic light eruption (PMLE), systemic lupus erythematous (SLE), xerodermapigmentosa) that could interfere with the study or increase risk to the subject. 5. Individuals with self-reported UNCONTROLLED metabolic conditions, such as diabetes, hypertension, hyper/hypothyroidism, hypercholesterolemia 6. Subjects who are taking medication for chronic conditions that may make a subject more sun sensitive (e.g., Tetracyclines, antifungals, certain diuretics, etc.) 7. Skin diseases on tested sites (e.g., photosensitivity disorders, etc.), which may influence the outcome of the study 8. Wearing of a full head covered ski mask. 9. An individual who has any condition which in the PI's judgment makes the candidate an inappropriate subject for study participation 10. Subjects who are related to those persons involved directly or indirectly with the conduct of this study (i.e., PI, sub-investigators, study coordinators, other site personnel, employees of Johnson & Johnson subsidiaries, contractors of Johnson & Johnson, and the families of each) 11. Individuals with a condition or situation which, in the PI's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study 12. Individual viewed by the PI as not being able to complete the study

Design outcomes

Primary

MeasureTime frameDescription
Side-by-side Comparison (overall difference) of Sunburn.Day 2The side-by-side comparison utilized the following condensed two side overall difference scale: L1 = subject's left side noticeably more sunburned than right side, 0= no difference in sunburn, R1= subject's right side noticeably more sunburned than left side. The 0 outcomes were excluded from the analysis.

Secondary

MeasureTime frameDescription
Difference in Erythema Score Between Left and Right Sides at Day 2Day 2Erythema was assessed using a scale of 0 = no burn, 1 = possible burn, not clearly defined; 2 = defined redness clearly caused by UV; 3 = severe sunburn with pronounced redness; and 4 = edema and blisters

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026